Bio-Techne Corp (TECH, Financial) has recently captured the attention of investors and financial analysts with its strong financial performance and promising growth prospects. With a current share price of $75.53, the company has experienced a notable daily gain of 6.76%, despite a three-month change of -7.04%. A detailed analysis, supported by the GF Score, indicates that Bio-Techne Corp is poised for significant future growth.
What Is the GF Score?
The GF Score is a proprietary stock performance ranking system developed by GuruFocus. It evaluates stocks based on five key aspects: financial strength, profitability, growth, GF Value, and momentum. These components are weighted differently to calculate a comprehensive score ranging from 0 to 100, with 100 indicating the highest potential for outperformance. Bio-Techne Corp boasts a GF Score of 95, signaling strong future performance potential.
- Financial strength rank: 8/10
- Profitability rank: 9/10
- Growth rank: 9/10
- GF Value rank: 10/10
- Momentum rank: 8/10
Understanding Bio-Techne Corp's Business
Bio-Techne Corp, headquartered in Minnesota, is a prominent life sciences manufacturer serving the pharmaceutical, biotechnology, academic, and diagnostic markets. The company operates through two main segments: protein sciences and diagnostics and genomics. Protein sciences, which account for 75% of revenue, include reagents and instruments for research, notably antibodies for protein analysis. The diagnostics and genomics segment, making up 25% of revenue, offers diagnostic reagents and molecular diagnostics products. Bio-Techne Corp generates approximately 55% of its revenue from the United States, with significant operations in Europe, the Middle East, Africa, the UK, and the Asia-Pacific region.
Financial Strength and Stability
Bio-Techne Corp's financial robustness is evident in its impressive Interest Coverage ratio of 15.44, significantly surpassing the benchmark set by investment guru Benjamin Graham. Additionally, the company's Altman Z-Score of 12.17 indicates a strong buffer against financial distress, and a Debt-to-Revenue ratio of 0.36 showcases prudent debt management.
Profitability and Growth Insights
Bio-Techne Corp's Profitability Rank is impressive, with an Operating Margin that has consistently improved over the past five years. The company's Growth Rank is also notable, with a 3-Year Revenue Growth Rate of 7.8%, outperforming a significant portion of its industry peers. This is complemented by a strong EBITDA growth, further underscoring its expansion capabilities.
Conclusion: A Promising Investment?
Considering Bio-Techne Corp's robust financial strength, impressive profitability, and consistent growth metrics, the GF Score highlights the company's strong position for potential market outperformance. Investors looking for similar opportunities can explore other high-scoring companies using the GF Score Screen provided by GuruFocus.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
